Answers From The Lab podcast

Player FM - Internet Radio Done Right

24 subscribers

اضافه شده در four سال پیش

محتوای ارائه شده توسط Mayo Clinic Laboratories. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط Mayo Clinic Laboratories یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

No Limit Leadership

1
81: From Nothing to a Billion: The Leadership Playbook They Don’t Teach You w/ Harry L Allen 36:51

۸ روز پیش36:51

پخش در آینده

لیست ها

پسندیدن

دوست داشته شد

36:51

Traditional banks often lack personalized service, and local businesses struggle to find true partnership in financial institutions. Meanwhile, higher education faces scrutiny over relevance and ROI in a world where information is nearly free. Harry Allen helped launch Studio Bank to blend technology with high-touch service, fueled by community investment. At Belmont, he's applying the same entrepreneurial mindset to modernize university operations and embed practical learning experiences, like a one-of-a-kind partnership with Dolly Parton, into academia. In this episode, Harry L. Allen, co-founder of Studio Bank and now CFO at Belmont University, unpacks the bold vision behind launching a community-first bank in a city dominated by financial giants. He shares the leadership lessons that shaped his journey, how to lead through crisis, and why mentorship is the key to filling today's leadership vacuum. Key Takeaways Leveraging both financial and social capital creates a unique, community-first banking model. High-tech doesn't mean low-touch, Studio Bank fused innovation with personal relationships. Leadership means showing up, especially during crisis. Universities must shift from being information hubs to delivering real-world experience. Succession and mentorship are vital to cultivating the next generation of leaders. Chapters 00:00 Introduction to Harry L. Allen 01:49 The Birth of Studio Bank 04:29 Leveraging Technology in Community Banking 07:25 The Courage to Start a New Venture 10:37 Leadership Challenges in High Growth 13:02 Leading Through Crisis: The COVID Experience 17:55 Transitioning from Banking to Education 21:16 The Role of Leadership in Higher Education 25:16 Adapting to Challenges in Higher Education 30:04 The Leadership Vacuum in Society 33:17 Advice for Emerging Leaders 35:21 The American Dream and Community Impact No Limit Leadership is the go-to podcast for growth-minded executives, middle managers, and team leaders who want more than surface-level leadership advice. Hosted by executive coach and former Special Forces commander Sean Patton, this show dives deep into modern leadership, self-leadership, and the real-world strategies that build high-performing teams. Whether you're focused on leadership development, building a coaching culture, improving leadership communication, or strengthening team accountability, each episode equips you with actionable insights to unlock leadership potential across your organization. From designing onboarding systems that retain talent to asking better questions that drive clarity and impact, No Limit Leadership helps you lead yourself first so you can lead others better. If you're ready to create a culture of ownership, resilience, and results, this leadership podcast is for you.…

Answers from the Lab

اشتراک گذاری

خانه سری•Feed

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

358 قسمت

#Science #Fitness #Medicine #Mayo Clinic Podcast For Laboratory #Laboratory Medicine #Healthcare #Lab #Mayo Clinic #Clinical #Dlmp #Morice #Pritt

Answers from the Lab

24 subscribers

updated ۵ روز پیش

اشتراک گذاری

خانه سری•Feed

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.

358 قسمت

#Science #Fitness #Medicine #Mayo Clinic Podcast For Laboratory #Laboratory Medicine #Healthcare #Lab #Mayo Clinic #Clinical #Dlmp #Morice #Pritt

همه قسمت ها

Answers from the Lab

1
How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D. 14:23

۵ روز پیش14:23

14:23

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed . They explore: The significant interest in diagnostics for the advancement of cancer care. The Joint Commission’s collaboration with the Coalition for Health AI to establish guidelines for the responsible use of artificial intelligence. The growing understanding that platforms offer an opportunity to expand access and make knowledge more accessible as platform-driven solutions become a reality. The role of laboratorians in guiding the ethical and effective use of data and emerging technologies — and what this means for educating future healthcare professionals. The critical importance of values and ethics in deploying new tools.…

Answers from the Lab

1
Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D. 6:51

۷ روز پیش6:51

6:51

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay ( Mayo ID: LBCS ) improves upon standard blood tests for Wilson's disease. The new test measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound. (00:32) Can you tell us a little bit about yourself and your background? (01:33) Could you give us a brief overview of this assay? (02:47) Which patients should have this testing, and when should it be performed? (03:48) How would the results be used in patient care?…

Answers from the Lab

1
Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D. 11:49

14 روز پیش11:49

11:49

John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test detects antihypertensive medications in urine, providing evidence of whether patients are absorbing their medications or whether a new treatment approach might be needed. Speaker 3: (00:33) Could you tell us a little about yourselves and your backgrounds? Speaker 3: (01:41) Dr. Taler, could you provide us with a brief background on resistant hypertension? Speaker 3: (03:43) Can you provide a little bit more background on patients who aren't taking their medications? Speaker 3: (05:11) How do physicians currently assess whether patients are taking their medications? Speaker 3: (07:03) Dr. Lieske, could you tell us how this new assay can be used to help physicians manage their patients with hypertension? Speaker 3: (09:43) Dr. Taler, can you tell us how doctors can use this new testing to manage their patients?…

Answers from the Lab

1
Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S 16:20

19 روز پیش16:20

16:20

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Div Dubey, M.B.B.S. , a neurologist and co-director of the Clinical Neuroimmunology Laboratory at Mayo Clinic, explore the topic of peripheral neuropathy. Their discussion covers: The high prevalence of peripheral neuropathy and why early diagnosis is important. The complexities involved in diagnosing the condition. Symptoms that should prompt clinicians to order advanced testing early in the diagnostic process. How algorithms are enhancing the use of testing to complement other diagnostic tools. Ongoing discovery related to specific antibodies associated with neuropathies. Learn more in our e-book, " Peripheral neuropathy: Cutting through diagnostic dissonance with an algorithmic approach ."…

Answers from the Lab

1
Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D. 12:21

21 روز پیش12:21

12:21

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay ( Mayo ID: ADVQU ) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children. (01:14) Could you give us a brief overview of this assay? (02:06) Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method? (04:00) When is this test typically ordered for transplant patients? Is it used throughout their treatment? (06:56) Could an immunocompromised person be unknowingly infected? (07:31) Is our quantitative method approved for pediatric patients? (08:00) How are the test results used to treat patients? (10:36) What other infections might providers consider alongside adeovirus?…

Answers from the Lab

1
Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D. 14:32

۵ weeks پیش14:32

14:32

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, discuss global trends in diagnostic manufacturing and their implications for laboratory professionals. Topics include: Emerging innovations in mass spectrometry, next-generation sequencing, automation, and artificial intelligence. Fierce competition in the global manufacturing landscape as new companies enter the market. Geopolitical dynamics influencing where innovations are deployed. Why laboratory professionals need to drive innovation implementation to maximize benefits for clinicians and their patients.…

Answers from the Lab

1
Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D. 22:05

۷ weeks پیش22:05

22:05

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, to discuss the value laboratories deliver for their entire health system. They cover how laboratories impact: Growth in revenue Growth in lab charges Growth in ancillary services Hospital length of stay Control over expenses You can also find more in-depth information on this topic in “ Maximizing your health system’s financial performance ,” a white paper with data-driven ways laboratories support their organizations.…

Answers from the Lab

1
Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D. 13:40

۹ weeks پیش13:40

13:40

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases. They cover: Different diseases patients can get from ticks. Disease prevention, including Dr. Pritt’s A through Z flash cards with tips for people to protect themselves from infectious insects. Laboratory medicine’s valuable role in testing and educating providers to diagnose patients quickly and accurately. Clinical areas most likely to encounter patients with tick-borne diseases. Reliable sources for details about the prevalence of different diseases around the country (e.g., U.S. Centers for Disease Control and Prevention (CDC) and Mayo Clinic Laboratories ).…

Answers from the Lab

1
Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D. 22:09

11 weeks پیش22:09

22:09

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion . They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test. They covered: Details about how the cerebrospinal fluid biomarker test ( Mayo ID: ASYNC ) benefits patients exhibiting signs and symptoms of clinically uncertain cognitive decline or clinically uncertain Parkinsonian syndromes. Groundbreaking science on proteins that Amprion leveraged to create a solution that meaningfully impacts patient care and provides value to clinicians. Information physicians receive from the test, and when they should consider ordering it for their patients. Opportunities to change diagnostic journeys by providing accurate, early diagnosis with SAAmplify–αSYN.…

Answers from the Lab

1
Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. 10:34

12 weeks پیش10:34

10:34

Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the patient from the arsenic source to ease symptoms and prevent cancer risk. (00:33) Do you mind telling us a little bit about yourself and your background? (01:45) Could you please provide us with an overview of arsenic, how people get exposed, and the laboratory testing for arsenic and arsenic speciation? (05:25) Which patients should have this testing, and when should it be performed? (06:57) What alternative test options are available, and how does testing at Mayo Clinic compare? (08:37) How are the results used in patient care?…

Answers from the Lab

1
What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D. 12:05

13 weeks پیش12:05

12:05

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration’s (FDA) oversight of lab-developed tests (LDT). They covered: Details about the ruling to vacate the FDA’s rule on LDT oversight. What LDT oversight might look like in the future. How the laboratory medicine industry can help create an oversight approach that is positive for both patients and innovation.…

Answers from the Lab

1
Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP 15:20

13 weeks پیش15:20

15:20

Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in survival of the transplanted organ. (00:32) Could you provide us a with little bit about your background and yourself? (03:45) Will you please provide a brief overview of Mayo test 3A5Q? (06:56) Which patients should have this testing, and when should it be performed? (08:15) What alternative or complementary tests should be considered? (09:25) How are the results used in patient care? (10:38) Will you help the audience understand the significance of monitoring tacrolimus levels for transplant rejection? (12:53) What alleles are included in this test?…

Answers from the Lab

1
Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D. 11:09

14 weeks پیش11:09

11:09

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence , to discuss liquid biopsy cancer testing . Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA. During their conversation, Dr. Morice and Dr. Tan explore: Inspiration for developing the liquid biopsy. Features that differentiate LiquidHALLMARK® from existing cancer tests. Patients who will benefit from the test and how an oncologist might use the results. The future potential of liquid biopsy advancements.…

Answers from the Lab

1
The Emergence of Retail Health: Bill Morice, M.D., Ph.D. 14:15

15 weeks پیش14:15

14:15

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, to discuss the evolution of retail health. They cover several key topics, including: The emergence of retail health locations. Three types of care that are well-suited for a retail approach to healthcare. The importance of incorporating diagnostics when designing retail health. Keep up with the latest diagnostic news and Dr. Morice's insights on LinkedIn and X .…

Answers from the Lab

1
Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D. 14:00

17 weeks پیش14:00

14:00

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , CEO and president of Mayo Clinic Laboratories, to discuss infectious disease activity around the nation. They cover: The high prevalence of influenza A, avian influenza, measles, and COVID-19. Reliable resources for information on the spread of infectious diseases. Prevention measures and their impact on the spread of infectious diseases. The risks associated with multiple infectious diseases circulating simultaneously at high rates.…

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.